Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

Community Oncology Alliance Logo COA Responds to CMS Draft Guidance with Urgent Call for Action to Prevent Practice Closures and Protect Pa ...

President Trump's order calls for correcting this imbalance. The Republican-backed EPIC Act offers the clearest solution, ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare ...

In other countries, the government negotiates with pharmaceutical companies directly to set a single market price. In the U.S ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...